Perspective on Antiarrhythmic Drug Combinations
- PMID: 36787682
- DOI: 10.1016/j.amjcard.2023.01.035
Perspective on Antiarrhythmic Drug Combinations
Abstract
Physicians use multiple drugs in combination to treat hypertension, heart failure, diabetes mellitus, angina, hyperlipidemia, and many other cardiovascular conditions and risk factors. However, administering antiarrhythmic drugs (AAD) in combination is rarely discussed. Yet, the possibility of increasing efficacy and/or tolerance and/or safety of AADs (by adding mechanisms, offsetting adverse mechanisms, and/or using lower doses) exists. Unfortunately, this topic has not been reviewed in any contemporary cardiac literature of which we are aware, although information regarding AAD combinations has been published. In conclusion, and accordingly, this review discusses the possibility of using AAD combinations for both ventricular arrhythmias and atrial fibrillation, in which the rationale for such combinations, considerations for such combinations, and supporting literature are covered.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosures Dr. Reiffel is an investigator and/or consultant for J&J, Sanofi, Acesion, Amarin, InCarda Therapeutics; speakers bureau for Sanofi. Dr. Kowey is an investigator and/or consultant for AbbVie, Milestone, InCarda Therapeutics, Huya, Sanofi, Anthos, and Acesion. Dr. Robinson has no conflicts of interest to declare.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
